Physician profile
Amy Chan
NPI 1235640525
$1,331.63
in general payments reported to CMS, 2019-2025
15 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $150 · 2023: $57.72 · 2024: $485 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $753.43 | 2022-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Tornier Perform Reversed Augmented Glenoid |
| Sawtooth Surgical Solutions INC | $149.31 | 2025 | |
| Medtronic, INC. | $107.68 | 2021-2023 | |
| Heron Therapeutics, INC. | $103.96 | 2021-2022 | |
| Smith+Nephew, INC. | $39.19 | 2024 | Pico 7 |
| Ferring Pharmaceuticals INC. | $25.94 | 2025 | Euflexxa |
| Novo Nordisk INC | $24.67 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.00 | 2022 | |
| Mylan Specialty L.P. | $17.67 | 2021 | |
| Linvatec Corporation | $17.52 | 2024 | Biobrace 23mm |
| Olympus America INC. | $16.53 | 2025 | Itind System |
| Baxter Healthcare | $14.64 | 2023 | Floseal |
| Solventum Corporation | $14.25 | 2025 | Prevena |
| Pfizer INC. | $12.00 | 2021 | |
| Orthofix Medical, INC. | $10.84 | 2025 | Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.